🧠AI Analysis
Rethinking Metabolic Risk in Lean Patients with MASLD
Recent analysis highlights the clinical oversight of metabolic dysfunction-associated steatotic liver disease in patients with a normal body mass index.
Recent analysis highlights the clinical oversight of metabolic dysfunction-associated steatotic liver disease in patients with a normal body mass index.
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.